
Core Outcomes Set for Trials in People With Coronavirus Disease 2019
2020; Lippincott Williams & Wilkins; Volume: 48; Issue: 11 Linguagem: Inglês
10.1097/ccm.0000000000004585
ISSN1530-0293
AutoresAllison Tong, Julian Elliott, Luciano César Pontes Azevedo, Amanda Baumgart, Andrew D. Bersten, Lilia Cervantes, Derek P. Chew, Yeoungjee Cho, Tess E Cooper, Sally Crowe, Ivor S. Douglas, Nicole Evangelidis, Ella Flemyng, Elyssa Hannan, Peter Horby, Martin Howell, Jaehee Lee, Emma Liu, Eduardo Lorca, Deena Lynch, John C. Marshall, Andrea Matus González, Anne McKenzie, Karine Manera, Charlie McLeod, Sangeeta Mehta, Mervyn Mer, Andrew Conway Morris, Saad Nseir, Pedro Póvoa, Mark Reid, Yasser Sakr, Jenny I. Shen, Alan R Smyth, Tom Snelling, Giovanni FM Strippoli, Armando Teixeira‐Pinto, Antoní Torres, Tari Turner, Andrea K. Viecelli, Steve Webb, Paula Williamson, Laila Woc-Colburn, Junhua Zhang, Jonathan C. Craig,
Tópico(s)Hip and Femur Fractures
ResumoThe outcomes reported in trials in coronavirus disease 2019 are extremely heterogeneous and of uncertain patient relevance, limiting their applicability for clinical decision-making. The aim of this workshop was to establish a core outcomes set for trials in people with suspected or confirmed coronavirus disease 2019.
Referência(s)